Vision Screening and Vision Loss–Related Conditions Among American Indian or Alaska Native Children

• by Laurel E. Cederberg, Rachael L. Rivard, Elyse O. Kharbanda, Ugochinyere V. Ukah, Cassaundra L. Mohawk, Gabriel C. Cederberg

• July 13, 2026

FDA approves first therapy for warm autoimmune hemolytic anemia

The phase 2/3 ENERGY trial evaluated durable hemoglobin response with nipocalimab vs placebo in adults with warm autoimmune hemolytic anemia.

• by Kathryn Wighton

• August 25, 2026

• 3 min

Nebulized epinephrine for croup in children: an updated systematic review

• by Yonggang Wei, Lei Li, Nian Wei, Yuanlin Pu, Jihua Zhao, Ping Xiong

• August 26, 2026

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• August 28, 2026

• 5 min